Close
0
You have no items in your order cart.
Search
Filters

Intramammary Preparation

View as Grid List
Sort by
Display per page

Bovaclox D.C - 120

104530
Bovaclox DC Intramammary Suspension is formulated for use in the dairy cow (including heifers) at the point of drying off, that is immediately after the last milking of the lactation in order to treat existing mastitis and to provide protection against further infections during the dry period. Bovaclox DC Intramammary Suspension is a useful aid in reducing the incidence of summer mastitis in dry cows at risk. Do not use on cows which have a very short dry period. Not intended for use within 45 days of calving. Milk for human consumption may only be taken from 120 hours after calving. Should a cow calve earlier than 45 days after the last treatment, milk for human consumption may only be taken from 45 days plus 120 hours after the last treatment. Active ingredient: Cloxacillin, Ampicillin

Bovaclox D.C.Extra - 120

134010
Bovaclox DC Xtra is formulated for use in the dairy cow at the point of drying off, that is, immediately after the last milking of the lactation in order to treat existing mastitis and to provide protection against further infections during the dry period. Bovaclox DC Xtra is a useful aid in reducing the incidence of summer mastitis in heifers and dry cows at risk. Do not use on cows which have a very short dry period. Not intended for use within 49 days of calving. Milk for human consumption may only be taken from 156 hours after calving. Should a cow calve earlier than 49 days after the last treatment, milk for human consumption may only be taken from 49 days plus 156 hours after the last treatment. VPA 10999/056/001. Active ingredient: Cloxacillin, Ampicillin

Boviseal D.C - 120

106211
Boviseal is indicated for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of sub clinical mastitis in cows at calving, and of clinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving). It is recommended that Boviseal be used as part of a herd approach to dry cow management and mastitis control. Cows considered likely to be free of sub clinical mastitis should be given Boviseal at drying off according to the criteria below. Other animals should be managed in accordance with an approved mastitis control plan or specific veterinary advice Active ingredient: Bismuth Subnitrate

Cefimam - 120

127404
For the treatment of clinical mastitis in the lactating cow caused by bacteria susceptible to cefquinome, namely Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae, Escherichia coli. Each pre-filled syringe of 8 g contains: Cefquinome 75 mg (as Cefquinome Sulfate)

Cephaguard - 60

132271
For the treatment of subclinical mastitis at drying off and the prevention of new bacterial infections of the udder during the dry period in the dairy cow caused by the following cefquinome-sensitive organisms: Streptococcus uberis, Streptococcus dysgalactiae, Streptococcus agalactiae, Staphylococcus aureus, coagulase negative staphylococci. Active ingredient: Cefquinome

Cepralock - 144

161384
Teat sealant for the prevention of new intramammary infections throughout the dry period. Active ingredient: Bismuth subnitrate heavy 2.6 gram(s)

Cepralock - 24

161394
Teat sealant for the prevention of new intramammary infections throughout the dry period. Active ingredient: Bismuth subnitrate heavy 2.6 gram(s)

Ceprashort D.C 144

165265
For dairy cows at drying off. For the treatment of subclinical mastitis at drying-off caused by Staphylococcus Aureus, coagulase-negative staphylococci, Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis susceptible to cefapirin. POM product. For a short dry cow period (32 days), with a short withdrawal time, making short work of pathogens.

Ceprashort D.C 20

165255
For dairy cows at drying off. For the treatment of subclinical mastitis at drying-off caused by Staphylococcus Aureus, coagulase-negative staphylococci, Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis susceptible to cefapirin. POM product. For a short dry cow period (32 days), with a short withdrawal time, making short work of pathogens.

Cepravin - 20

110510
Cepravin Dry Cow is a long-acting intramammary suspension containing cefalonium, a semi-synthetic cefalosporin antibiotic. VPA 10277/018/001. Active ingredient: Cefalonium

Cepravin - 200

132021
Cepravin Dry Cow is a long-acting intramammary suspension containing cefalonium, a semi-synthetic cefalosporin antibiotic. Active ingredient: Cefalonium

Cepritec - 120

158314
Cepritect is licensed for the treatment of subclinical mastitis at drying-off and the prevention of new bacterial infections of the udder during the non-lactating period of cows caused by Staphylococcus aureus Streptococcus agalactiae Streptococcus dysgalactiae Streptococcus uberis Trueperella pyogenes Escherichia coli and Klebsiella spp. susceptible to cefalonium. The long-term persistence of cefalonium in the dry udder was examined and effective levels remained up to 10 weeks after infusion.